sanofi-aventis
|
Item 4. Information on the Company Introduction We are a global pharmaceutical
group engaged in the research, development, manufacture and marketing of healthcare products. In 2006, our net sales amounted to 28,373 million. Based on 2006 sales, we are the fourth largest pharmaceutical group in the world and the largest
pharmaceutical group in Europe (source: IMS/GERS consolidated sales year end 2006; all available channels). Sanofi-aventis is the parent of a consolidated group of com...
More from Zoominfo » |
|
Sanofi-Aventis
Furthermore, like Sanofi, we believe that GSK has a number of attractive, companyspecific attributes, such as its strong balance sheet, which should provide the company with the financial flexibility to pursue agreements or acquisitions ...
From
The Quality Stocks Stock Newsl...
- by Jonathan - 5 days ago
Sanofi-Aventis
While we believe Sanofi represents an attractive investment opportunity for the Fund on a stand-alone basis, the company, and the pharmaceutical industry ingeneral, are subject to inherent uncertainties whose outcomes are difficult to ...
From
qualitystocks.net Small-Cap an...
- by jonnyk4429 - 5 days ago
When will Sanofi-Aventis
Down -0.89% today(26-Aug-2008). The stock has recovered 7.8% from its recent low price of 32.11 which occurred on 23-Jun-2008. A close above 20-day moving average of 35.75 could mark low of 32.11 as a recent low. ...
From
askStockGuru.com Analysis - He...
- by info@askStockGuru.com (AskStockGuru.com) - 1 day ago
More blog posts from Google Blog Search
|
|